Massachusetts · 194th Legislature (2025-2026) · Bill
H 2216: An Act relative to the administration of anti-psychotic or other psychotropic substances to nursing home residents
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
H 2216 is a bill introduced in the Massachusetts House on February 27, 2025. According to its official title, it concerns: An Act relative to the administration of anti-psychotic or other psychotropic substances to nursing home residents. Primary sponsor: Sally Kerans (Democratic). It lists 4 additional sponsors. Most recent recorded action (April 23, 2026): Accompanied a study order, see H5338 (under House Rule 27).
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
By Representative Kerans of Danvers, a petition (accompanied by bill, House, No. 2216) of Sally P. Kerans and Carmine Lawrence Gentile relative to anti-psychotic or other psychotropic. Mental Health, Substance Use and Recovery.
Sponsors
Sponsors by party (alphabetical): Democratic 5
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Sally Kerans | Primary sponsor | Democratic | House | 13th Essex |
| Jamie Eldridge | Co-sponsor | Democratic | Senate | Middlesex and Worcester |
| Carmine Gentile | Co-sponsor | Democratic | House | 13th Middlesex |
| Natalie Higgins | Co-sponsor | Democratic | House | 4th Worcester |
| John Moran | Co-sponsor | Democratic | House | 9th Suffolk |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Accompanied a study order, see H5338 (under House Rule 27)
- Reporting date extended to Wednesday, March 18, 2026
- Hearing scheduled for 10/14/2025 from 01:00 PM-05:00 PM in A-2
- Senate concurred
- Referred to the committee on Mental Health, Substance Use and Recovery